Cardiol Therapeutics Inc. (CRDL)

NASDAQ: CRDL · IEX Real-Time Price · USD
1.620
+0.100 (6.58%)
At close: Feb 23, 2024, 4:00 PM
1.590
-0.030 (-1.85%)
After-hours: Feb 23, 2024, 5:38 PM EST

Cardiol Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Net Income
-30.93-31.64-20.64-13.68
Depreciation & Amortization
0.220.220.230.15
Share-Based Compensation
5.018.52.773.27
Other Operating Activities
-1.52-0.628.52-1.11
Operating Cash Flow
-27.22-23.54-9.13-11.38
Capital Expenditures
-0.07-0.01-0.04-0.42
Investing Cash Flow
-0.07-0.01-0.04-0.42
Share Issuance / Repurchase
098.7217.432.05
Debt Issued / Paid
-0.05-0.05-0.05-0.02
Other Financing Activities
--5.23-1.09-
Financing Cash Flow
-0.0593.4416.32.03
Exchange Rate Effect
2.92-0.01-0.060
Net Cash Flow
-27.3569.897.13-9.78
Free Cash Flow
-27.3-23.55-9.17-11.8
Free Cash Flow Margin
--29904.22%--
Free Cash Flow Per Share
-0.44-0.55-0.31-0.46
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).